10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
GILEAD SCIENCES, INC. | |||
Ticker: GILD Fiscal Year: 2015 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2015 10-K (Filed: Feb 24, 2016) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
| Operating Activities: | |||
| Net income | $ 18,106 | 12,059 | 3,057 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation expense | 161 | 125 | 103 |
| Amortization expense | 937 | 925 | 242 |
| Stock-based compensation expense | 382 | 360 | 252 |
| Excess tax benefits from stock-based compensation | (585) | (482) | (279) |
| Tax benefits from exercise and vesting of stock-based awards | 586 | 484 | 285 |
| Deferred income taxes | (393) | (236) | (98) |
| Other | (24) | 101 | 105 |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (1,397) | (2,578) | (315) |
| Inventories | (855) | 143 | (343) |
| Prepaid expenses and other assets | (90) | (371) | (170) |
| Accounts payable | 226 | (289) | (98) |
| Income taxes payable | 269 | 533 | 30 |
| Accrued liabilities | 2,632 | 2,013 | 312 |
| Deferred revenues | 374 | 31 | 22 |
| Net cash provided by operating activities | 20,329 | 12,818 | 3,105 |
| Investing Activities: | |||
| Purchases of marketable securities | (17,239) | (2,107) | (257) |
| Proceeds from sales of marketable securities | 4,792 | 807 | 494 |
| Proceeds from maturities of marketable securities | 719 | 52 | 78 |
| Other investments | 0 | (18) | 0 |
| Acquisitions, net of cash acquired | 0 | 0 | (379) |
| Capital expenditures | (747) | (557) | (190) |
| Net cash used in investing activities | (12,475) | (1,823) | (254) |
| Financing Activities: | |||
| Proceeds from debt financing, net of issuance costs | 9,902 | 7,932 | 0 |
| Proceeds from convertible note hedges | 784 | 2,543 | 2,774 |
| Purchases of convertible note hedges | 0 | (26) | 0 |
| Proceeds from issuances of common stock | 319 | 331 | 313 |
| Repurchases of common stock | (10,002) | (5,349) | (582) |
| Repayments of debt and other obligations | (997) | (4,779) | (4,440) |
| Payments to settle warrants | (3,865) | (4,093) | (1,040) |
| Excess tax benefits from stock-based compensation | 585 | 482 | 279 |
| Payment of contingent consideration | (3) | (101) | 0 |
| Payment of dividends | (1,874) | 0 | 0 |
| Contributions from noncontrolling interest | 188 | 35 | 152 |
| Net cash used in financing activities | (4,963) | (3,025) | (2,544) |
| Effect of exchange rate changes on cash and cash equivalents | (67) | (56) | 2 |
| Net change in cash and cash equivalents | 2,824 | 7,914 | 309 |
| Cash and cash equivalents at beginning of period | 10,027 | 2,113 | |
| Cash and cash equivalents at end of period | 12,851 | 10,027 | 2,113 |
| Supplemental disclosure of cash flow information: | |||
| Interest paid, net of amounts capitalized | 529 | 330 | 238 |
| Income taxes paid | 3,137 | 2,060 | 1,051 |
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2015 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |